Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. [1]
Sheppard, HW (2005). «Inactivated- or killed-virus HIV/AIDS vaccines». Curr Drug Targets Infect Disord5: 131-41. PMID15975019. doi:10.2174/1568005054201599.
radio-canada.ca
ici.radio-canada.ca
Promising vaccine against HIV in development in Ontario [3]